Background. Most studies investigate the association between the baseline Romano-Charlson comorbidity index (CCI) and survival on hemodialysis (HD). Few consider the effect of progression in the CCI score (CCIp) on patient survival before HD initiation. That is CCIp = CCI −1 − CCI −3 , where CCI −1 is the CCI score in the first year before HD initiation, and CCI −3 is the CCI score in the third year before HD initiation. The present study investigated whether CCIp affects the survival of incident HD patients.
Methods. Using the National Health Insurance (NHI) Research Database of Taiwan, we recruited 7391 adult incident HD patients in the year 2006 for this historical cohort study. We followed the cohort until the end of 2007. Using the Romano-Charlson method, each comorbidity was assigned a score of 1, 2, 3 or 6. The scores were then summed to produce a total score (CCI), which predicts mortality. The log-rank test and a Cox regression model were used to analyze the association between CCIp and survival, and the risk markers of survival.
Results. Diabetes, ulcers, congestive heart failure, chronic pulmonary disease and cerebrovascular disease were the most common comorbid conditions. The median CCI −3 was 2 (interquartile range 0-3). The overall survival rate in 1 year was 82.8%. In incident patients with a CCI −3 score of <3, the rate was 85.1%, and in patients with a CCI −3 score of ≥3, the rate was 76.8%. Each increase of one point in the CCI −3 score (HR = 1.69, 95% CI 1.42-2.01) and the CCIp (HR = 1.22, 95% CI 1.17-1.27) affected survival in HD patients. Conclusions. The CCI −3 and CCIp before HD initiation are valuable predictors of survival in incident patients.
I N T R O D U C T I O N
As people age and live longer, they are more likely to develop comorbid conditions [1, 2] . Most patients begin hemodialysis (HD) with comorbid conditions [3, 4] , which had been shown to progress after HD initiation [5, 6] and which are associated with mortality in HD patients [7] [8] [9] [10] . Despite the progression of comorbid conditions, most studies investigate the association between baseline comorbidities and survival on HD [7, 8, 11] . The progression of comorbid conditions during pre-dialysis before HD initiation has rarely been investigated. The progression of comorbidities during pre-dialysis is therefore worth investigating. The factors that progress during pre-dialysis care can be good predictors of survival on dialysis-perhaps even better predictors than the factors measured at the start of dialysis.
Of the various methods available to measure comorbidity [7, 12, 13] , the Romano-Charlson comorbidity index (CCI) which is based on the International Classification of Disease, 9th Revision, Clinical Modification (ICD-9-CM) codes in claims data has been widely used in the analyses of the impact of comorbidities on mortality [14] . We, therefore, used claims data from the National Health Insurance (NHI) program in Taiwan to evaluate the progression of comorbidities during pre-dialysis care, and to investigate the relationship between that progression before HD initiation and survival in incident patients.
M AT E R I A L S A N D M E T H O D S
Healthcare system and data source In Taiwan, as in many other industrialized nations, the demand for universal healthcare led to the creation of the NHI program, which began on 1 March 1995. All medical institutions must submit standard claims documents for medical expenses on a computerized form that lists the outpatient clinic, the admission and discharge dates, the patient's identification number, sex, date of birth and diagnosis codes for the admission, which are taken from the ICD-9-CM. Those codes, which consist of a principal diagnosis and up to four secondary diagnoses for inpatient care and two secondary diagnoses for outpatient care, facilitate the analysis of healthcare patterns. 
Dependent variable
Using 90 days (3 months) after HD start as the baseline, the 1 year survival rate was calculated from the 91 st day after HD initiation to death. Patients who were alive after 1 year of follow-up were censored.
Independent variable
The CCI is a common comorbidity measure that was created by Charlson and colleagues to standardize the weight of a comorbid condition. The index consists of a list of 19 diagnoses obtained from a review of the patient's medical chart. Each condition is assigned a score of 1, 2, 3 or 6, depending on the risk of death associated with the condition. For a history of myocardial infarction, congestive heart failure, peripheral vascular disease, cerebrovascular disease, dementia, chronic pulmonary disease, rheumatologic disease, peptic ulcer disease, mild liver disease or diabetes, one point is assigned. For a cerebrovascular (hemiplegia) event, moderate-to-severe renal disease (excluded in this study's scale), diabetes with chronic complications and cancer without metastases, two points are assigned. For moderate or severe liver disease, three points are assigned and six points are assigned for a metastatic solid tumor or full-blown acquired immunodeficiency syndrome (AIDS, excluded in this study's scale because our dataset contained no AIDS patients regularly using HD). The scores for individual conditions are summed to yield a total score for predicting mortality.
Later, Romano used comprehensive ICD-9-CM codes to adapt the Charlson index. The Romano-Charlson index, therefore, reports more comorbidities than the original Charlson index did. The score on the Romano-Charlson comorbidity index (CCI) has been frequently used for risk adjustment purposes [9, 11, 12, 14, 16] .
In this study, we used the Romano CCI score before HD initiation and progression in that score as variables to predict survival in incident patients. Because all incident HD patients have a positive 'kidney disease' component, the only material difference between our modified CCI and the conventional CCI was the lack of an AIDS component in our regular HD patients. To account for the cumulative prevalence of comorbid conditions in incident patients before HD initiation (Figure 1 ), mild-to-moderate diabetes and diabetes with chronic complications were combined into a single comorbidity ('diabetes'), mild liver disease and moderate or severe liver diseases were combined into a single comorbidity ('liver disease') and malignancy and metastatic solid tumor were combined into a single comorbidity ('cancer').
The CCI in the third year before HD initiation (CCI −3 ) and the progression of the CCI score (CCIp) before HD initiation, calculated as CCI in the first year before HD initiation (CCI −1 ) minus (CCI −3 ) were used as predictors. To investigate whether the effect of progression in comorbidity during pre-dialysis care can be affected by the conditions of CCI −3 , we stratified CCI −3 into mild (CCI −3 < 3) and severe groups (CCI −3 ≥ 3), and evaluated the interaction between CCI −3 and CCIp. For a list of the diagnoses of comorbidities recorded in the NHI and used in the present study, see Appendix.
Covariates Demographic and clinical information of the patients, ascertained from the primary and secondary diagnosis codes in the claims data, included sex, age (18-64, 65-74, ≥75 years), education (≤6 years, 7-9 years, >9 years), marital status (married, single, divorced/separated, widowed) and stage of referral to nephrologists (early or late). Referral to a nephrologist was defined as the time at which nephrology care began, according to the NHI billing data. Patients who had been under a nephrologist's care for at least 4 months before HD initiation were considered early referrals [17] .
Statistical analysis
The SAS 9.1.3 statistical software application for Windows (SAS Institute Inc., Cary, NC) was used for data management and analysis. Basic descriptive analyses for continuous variables (mean ± standard deviation) and categorical variables (frequencies and percentages) were used to characterize the patients. A bar chart illustrates the comorbid conditions before HD initiation. To explore the effect of CCIp on the survival of these incident HD patients, a log-rank test and the Kaplan-Meier method were used. Patients were analyzed overall (CCI) and in two groups: patients with a CCI −3 of <3 and patients with a CCI −3 of ≥3. The SPSS 15.0 statistical software application for Windows (SPSS Inc., Chicago, IL) was used to generate Kaplan-Meier survival curves for each CCIp group.
Cox regression was also used to investigate whether CCIp, CCI −3 and the interaction between severity of CCI −3 and CCIp were good predictors of survival in the HD patients, after adjustment for age, sex, education, marital status and early referral to nephrology. A two-tailed P < 0.05 was considered statistically significant.
Cumulative prevalence of comorbid conditions in incident patients before HD initiation. ESRD, end-stage renal disease; MI, myocardial infarction; CHF, congestive heart failure; PAOD, peripheral vascular disease; CVD, cerebrovascular disease; Rheum. Disease, rheumatologic disease; COPD; chronic pulmonary disease; DM, diabetes mellitus.
R E S U LT S

Basic characteristics
The five most common comorbidities were congestive heart failure, cerebrovascular disease, chronic pulmonary disease, peptic ulcer and diabetes. (Figure 1) The prevalence of these five common comorbidities was not significantly different between male and female patients. Of the 7391 patients, 3614 (48.9%) were female. In the overall group, the mean age was 63.7 ± 13.3 years. 4522 patients (61.2%) had ≤6 years' education and 4842 patients (65.5%) were married. The proportion of patients who were referred early to nephrology was 31.9%. Among these incident patients, the median CCI −3 was 2 (IOR 0-3). The median CCIp was 1 (IOR 0-2) ( Table 1 ). The prevalence of comorbid conditions before HD initiation was found to increase with time.
Effect of CCI −3 and CCIp on survival of incident patients
We observed a negative association between the CCIp and survival in incident patients overall (P < 0.0001), and in incident patients with a CCI −3 of <3 (P < 0.0001) and a CCI −3 of ≥3 (P < 0.0001). The overall survival rate at 1 year was 82.8%,. It was 85.1% in incident patients with a CCI −3 of <3, and 76.8% in patients with CCI −3 of ≥3. (Table 2, Figure 2) .
Compared with patients having a CCIp of 0, patients in the overall cohort with CCIp of 1, 2, 3 and 4+ had crude hazard ratios for death of 1.37, 1.79, 2.25 and 2.67, respectively (P < 0.0005). In the group with a CCI −3 of <3, the crude hazard ratios were 1.47, 2.06, 2.67 and 3.18, respectively (P < 0.005), and in the group with a CCI −3 of ≥3, the crude hazard ratios were 1.47, 1.77 and 2.10 for patients with a CCIp of 2, 3 and ≥4 (P < 0.05, Table 3 ). Survival time was calculated 90 days after HD start. The Kaplan-Meier method was used to estimate the 1-year survival rate. The log-rank test was used to compare survival between groups. A two-tailed P < 0.05 was considered statistically significant. CCI, Romano-Charlson comorbidity index; CCI −3 , CCI score in the third year before HD initiation; CCIp, progression in the CCI score (CCI score in the first year before HD initiation minus CCI score in the third year before HD initiation).
Significant risk markers associated with survival
The multivariate Cox regression analysis showed that male sex, older age, education ≤6 years, single or widowed status, late-referral, high CCI −3 and high CCIp were all independent risk markers for survival (P < 0.05, Table 4 ). For each incremental increase in the CCIp, the rise in the adjusted hazard ratio was 1.22 (95% CI 1.17-1.27; P < 0.0001). Although incident patients with a CCI −3 of ≥3 had a higher risk of mortality (HR = 1.69; 95% CI 1.42-2.01; P < 0.0001), the interaction between CCIp and CCI −3 severity was not significant. The incident patients with a CCI −3 of ≥3 had a lower CCIp effect (HR 0.94; 95% CI 0.87-1.01; P = 0.1081) than did patients with a CCI −3 of <3 (Table 4) .
D I S C U S S I O N
Previous reports [5, 6, 18] considered baseline comorbid conditions at the time of HD initiation and change in comorbid conditions after HD initiation to be predictors of survival in incident dialysis patients. However, the present study is the first to use a nationally representative HD dataset to show that the CCI −3 score and progression in comorbid conditions before HD initiation (CCIp) might be able to predict survival in incident HD patients. The factors that progress during pre-dialysis care can be good predictors of survival on dialysis-perhaps even better predictors than the factors measured at the start of dialysis.
The reduced survival of incident patients with a higher CCIp, compared with patients having a lower CCIp (P < 0.0001, Figure 2 and Table 3 ), may also imply that the severity of CCIp is an important factor in the survival of incident patients after HD initiation.
The other risk markers affecting survival in incident patients identified in the present study-male sex, older age, education ≤6 years, widowed status and late referral (Table 3) -are similar to those previously identified in the literature [19] [20] [21] [22] [23] [24] [25] .
F I G U R E 2 : Kaplan-Meier curves for 1-year survival by progression in the CCI score (CCIp = CCI score in the first year before HD initiation minus CCI score in the third year before HD initiation) in incident patients. Survival was calculated beginning 90 days after starting HD. The survival rate of incident patients declined as CCIp increased. A similar phenomenon was observed in incident patients with a CCI score of <3 (upper panel) and a CCI score of ≥3 (lower panel) in the third year before HD initiation. Table 3 . Hazard ratio by progression in the CCI score in incident HD patients CCI, Romano-Charlson comorbidity index; CCI −3 , CCI score in the third year before HD initiation; CCIp, progression in the CCI score, (CCI score in the 1 year before HD initiation minus CCI score in the 3 year before HD initiation); HR, hazard ratio; CI, confidence interval. Cox regression was used to assess the influence of survival on CCI −3 and CCIp.
The increase over time in the prevalence and severity of comorbid conditions in incident patients before HD initiation that we observed (Figure 1 ) further supports previous findings that patients with advanced chronic kidney disease tend to have more comorbidities [26] [27] [28] . That observation may be related to the combination of extracellular volume expansion, anemia, metabolic acidosis, malnutrition, hyperparathyroidism and the presence of poorly defined uremic toxins as the estimated glomerular filtration rate in these patients declines [26, 29, 30] .
Our study has several limitations. Information about factors such as smoking, which may affect survival, was not available in our study. However, as with all studies that use administrative datasets, the key comorbid conditions that contribute additional prognostic information over and above laboratory and clinical parameters were reported [31] . Under the reimbursement system, hospitals have to claim medical expenses from the NHI based on the diagnosis or treatment codes for the disease presented by their patients. The codes consist of a principal and up to four secondary diagnoses for inpatient care and two secondary diagnoses for outpatient care. In this study, we used all diagnosis codes for a full year to define the existing comorbidities. We, therefore, expect missing comorbidity information to be rare and unlikely to influence the result. Our study analyzed the data from only those patients who survived the pre-dialysis phase and who started HD treatment. Our conclusions about progression to end-stage renal disease (ESRD) or mortality may therefore not be applied to the entire population of pre-dialysis patients. However, nephrologists should be aware of the negative association between the CCIp and survival in incident patients. Our study also has several strengths. First, claims data from universal medical coverage in Taiwan allow for identification of population samples free from selection bias and of sufficient size to document outcomes. Second, by using insurance records that consist of comorbidity information, we could unambiguously analyze comorbid conditions and survival rates in the incident HD patients.
CO N C L U S I O N S
During the pre-dialysis phase, before HD initiation, the prevalence of comorbid conditions increased over time. The CCI −3 and CCIp were found to be valuable predictors of survival in incident patients. CI, confidence interval; HR, hazard ratio; CCI, Romano-Charlson comorbidity index; CCI − 3, CCI score in the third year before HD initiation; HD, hemodialysis; CCIp, progression in the CCI score (CCI score in the first year before HD initiation minus CCI score in the third year before HD initiation).
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